Page last updated: 2024-08-25

ranimustine and Abnormalities, Autosome

ranimustine has been researched along with Abnormalities, Autosome in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fujimoto, Y; Ishihara, S; Izumi, H; Kaneko, K; Kato, M; Kuraishi, Y; Nagase, D; Natori, K; Umeda, M	1
Harashima, S; Okamura, T; Takaki, K; Umeno, M	1

Other Studies

2 other study(ies) available for ranimustine and Abnormalities, Autosome

Article	Year
[Four cases of therapy-related leukemia in multiple myeloma]. Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Humans; Leukemia, Myeloid, Acute; Male; Melphalan; Middle Aged; Multiple Myeloma; Neoplasms, Second Primary; Nitrosourea Compounds; Prednisolone; Prednisone; Vincristine	2007
[A case of myelofibrosis that developed polycythemia vera following treatment with ranimustine and then acute myelogenous leukemia (M0)]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1996, Volume: 37, Issue:8 Topics: Antineoplastic Agents; Chromosome Aberrations; Chromosome Disorders; Disease Progression; Fatal Outcome; Female; Humans; Leukemia, Myeloid, Acute; Lymphocyte Activation; Middle Aged; Nitrosourea Compounds; Polycythemia; Primary Myelofibrosis	1996

Article

Year

[Four cases of therapy-related leukemia in multiple myeloma].

Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:1

Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Humans; Leukemia, Myeloid, Acute; Male; Melphalan; Middle Aged; Multiple Myeloma; Neoplasms, Second Primary; Nitrosourea Compounds; Prednisolone; Prednisone; Vincristine

2007

[A case of myelofibrosis that developed polycythemia vera following treatment with ranimustine and then acute myelogenous leukemia (M0)].

[Rinsho ketsueki] The Japanese journal of clinical hematology, 1996, Volume: 37, Issue:8

Topics: Antineoplastic Agents; Chromosome Aberrations; Chromosome Disorders; Disease Progression; Fatal Outcome; Female; Humans; Leukemia, Myeloid, Acute; Lymphocyte Activation; Middle Aged; Nitrosourea Compounds; Polycythemia; Primary Myelofibrosis

1996